Some patients who need general medical care before a dental intervention can suffer increased risk for poor outcomes if they have compromised access to care.
AMA J Ethics. 2022;24(1):E6-12. doi:
10.1001/amajethics.2022.6.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Dr Lisa M. Lee joins Ethics Talk to discuss her article, coauthored with Dr Anita L. Allen: "How Should Clinicians Own Their Roles as Past and Present Exacerbators of Health Inequity and as Present and Future Contributors to Health Equity?”